Compass Oncology’s groundbreaking Genetic Risk Evaluation and Testing (GREAT) program is a leader in personalized cancer-risk reduction. The team includes physicians and nurses with advanced expertise in cancer genetics. They have the experience to evaluate family history, provide knowledgeable guidance about cancer detection and prevention, and interpret the results of testing.
Lucy Langer, MD, MSHS
Dr. Lucy Langer is the director of the (GREAT) program. She brings more than 15 years of genetics experience to Compass Oncology. She has performed genetic research at Columbia University and at UCLA and is the National Medical Director for the US Oncology Cancer Genetics Program.
Lisa Clark, FNP, APNG
Lisa Clark's experience with women coping with ovarian cancer inspired her interest in genetic research and cancer prevention. She has advanced certifications as a Family Nurse Practitioner (FNP), an Advanced Oncology Certified Nurse Practitioner (AOCNP) and an Advanced Practice Nurse in Genetics (APNG).
Scientists have been able to identify several specific inherited mutations that can lead to cancer. The Hereditary Breast and Ovarian Cancer (HBOC) syndrome caused by mutations in the BRCA1 and BRCA2 genes is probably the best known. Hereditary Non-Polyposis Colon Cancer (HNPCC), or Lynch syndrome, comprises colon, ovarian and endometrial cancers. Other types of cancer caused by inherited gene mutations include kidney cancer, melanoma, brain tumors, prostate, pancreatic, and thyroid cancers.
To set up a personalized genetic risk evaluation call 503.297.7403